Does the use of financial incentives increase the take up rate of the human papillomavirus (HPV) vaccination in 16 - 18 year old females?

Financial incentives to increase uptake of human papillomavirus (HPV) vaccination: a randomised controlled trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN52339409

Enrollment

1000

Registered

2010-03-09

Start date

2010-02-01

Completion date

Unknown

Last updated

2016-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Human papillomavirus (HPV) vaccination / cervical cancer Cancer Malignant neoplasm of the cervix

Interventions

Those allocated to the control group are invited to attend a local community centre on three occasions to undergo HPV vaccination. Those allocated to the intervention group receive the same invitation

£20 for the first vaccination

£5 for the second

and £20 for the third).

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1. Female, aged between 16 and 18 years 2. Living in Birmingham

Exclusion criteria

Exclusion criteria: Feeling unwell at the time of presenting for vaccination

Design outcomes

Primary

Measure	Time frame
Proportion of participants who have the HPV vaccine when a financial incentive is offered, measured when participants attend one of the three community clinics in the trial	—

Secondary

Measure	Time frame
Quality of decision, assessed using a short form of the Multidimensional Measure of Informed Choice, measured when participants attend one of the three community clinics in the trial	—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026